Vincerx Pharma, Inc.
VINC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,437 | $4,987 | $2,942 | $7,923 |
| Short-Term Investments | $0 | $0 | $7,144 | $8,396 |
| Receivables | $0 | $1,041 | $1,063 | $1,018 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $249 | $382 | $599 | $864 |
| Total Curr. Assets | $4,686 | $6,410 | $11,748 | $18,283 |
| Property Plant & Equip (Net) | $0 | $0 | $1,516 | $1,791 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $1,331 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1,595 | $1,683 | $122 |
| Total NC Assets | $0 | $1,595 | $3,199 | $3,244 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,686 | $8,005 | $14,947 | $21,527 |
| Liabilities | – | – | – | – |
| Payables | $2,269 | $2,029 | $1,963 | $1,536 |
| Short-Term Debt | $0 | $0 | $1,274 | $2,472 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $351 | $3,252 | $2,187 | $1,324 |
| Total Curr. Liab. | $2,620 | $5,281 | $5,424 | $5,332 |
| LT Debt | $0 | $0 | $365 | $697 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $50 | $50 |
| Total NC Liab. | $0 | $0 | $415 | $747 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1,639 | $1,933 |
| Total Liabilities | $2,620 | $5,281 | $5,839 | $6,079 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $8 | $3 | $3 |
| Retained Earnings | -$194,186 | -$189,186 | -$181,192 | -$173,349 |
| AOCI | $170 | $119 | $104 | $24 |
| Other Equity | $196,081 | $191,791 | $190,193 | $188,770 |
| Total Equity | $2,066 | $2,724 | $9,108 | $15,448 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,686 | $8,005 | $14,947 | $21,527 |
| Net Debt | -$4,437 | -$4,987 | -$1,303 | -$4,754 |